TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026)
TriSalus Life Sciences posted quarterly Capital Expenditures of $141000.0 for Q1 2026, down 81.3% year-on-year from $754000.0 in Q1 2025, and up 2720.0% on a QoQ basis from $5000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of Capital Expenditures data on file, last reported at $141000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 81.3% year-over-year to $141000.0; the trailing twelve-month figure through Mar 2026 stood at -$545000.0 (down 149.59% YoY), and the FY2025 full-year result was $68000.0, down 80.29% from the prior year.
- Capital Expenditures for Q1 2026 stood at $141000.0, up from $5000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $754000.0 in Q1 2025 and bottomed at -$734000.0 in Q2 2025.
- The 5-year median for Capital Expenditures is $141000.0 (2026), against an average of $122363.6.
- The widest annual swing landed in 2023, when Capital Expenditures surged 82.35%; it then sank 98.55% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $204000.0 in 2022, then soared by 82.35% to $372000.0 in 2023, then decreased by 7.26% to $345000.0 in 2024, then tumbled by 98.55% to $5000.0 in 2025, then jumped by 2720.0% to $141000.0 in 2026.
- The last three Capital Expenditures figures came in at $141000.0 (Q1 2026), $5000.0 (Q4 2025), and $43000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | -734,000.00 |
| Jun 30, 2025 | -734,000.00 |
| Mar 31, 2025 | 754,000.00 |
| Mar 31, 2025 | 754,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 204,000.00 |
| Dec 31, 2022 | 204,000.00 |